Actionable news
All posts from Actionable news
Actionable news in GILD: Gilead Sciences, Inc.,

Jim Cramer Gives His Opinion On SYSCO And Gilead

Jim Cramer said on CNBC's Mad Money that he likes SYSCO Corporation SYY and he thinks it has more upside potential. He added that SYSCO is levered to the restaurant business, which is currently in a little bit of trouble because of a higher cost.

Cramer would not sell Gilead Sciences, Inc. GILD at the moment, because it's too inexpensive. The company has a big cash position and it can do various things to increase value. He explained that Gilead is currently struggling because people see it as a one trick pony. Cramer thinks that it's better than that and he believes that the biotech space is oversold.

© 2017 Benzinga does not provide investment advice. All rights reserved.